Metabolic disorders: FGF21 analogue shows promise in the clinic
- PMID: 24136394
- DOI: 10.1038/nrd4157
Metabolic disorders: FGF21 analogue shows promise in the clinic
Comment on
-
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.Cell Metab. 2013 Sep 3;18(3):333-40. doi: 10.1016/j.cmet.2013.08.005. Cell Metab. 2013. PMID: 24011069 Clinical Trial.
References
-
- Cell Metab. 2013 Sep 3;18(3):333-40 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
